1. |
Genetic research guiding the way to new ALS therapies? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
2. |
Issues in the treatment of anxiety disorders |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 3-4
Ed Susman,
Preview
|
|
摘要:
Some people say they would rather be dead than get up in front of an audience. That, says Professor Mark Pollack from Harvard Medical School, Boston, US, pinpoints them as a likely victim of social anxiety disorder - the most prevalent of the anxiety disorders which, at one point during a lifetime, may affect as many as 25% of the population. Professor Pollack, the chairman of a Pfizer-supported symposium on anxiety disorders at the 154th Annual Meeting of the American Psychiatric Association (APA) [New Orleans, US; May 2001], said that social anxiety disorder occurs in about 12% of the population, with the next most common anxiety disorders being post-traumatic stress disorder (PTSD; affecting 6% of the population), generalised anxiety disorder (4%) and panic disorder (3%).
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
3. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
4. |
High cost of AD care: will therapy cut costs? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
5. |
Selective αvβ3-blockade reduces macrophage infiltration, restenosis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
6. |
STI 571 active in patients with rare GI cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 7-8
Carmen Innes,
Preview
|
|
摘要:
For the first time, patients with advanced gastrointestinal (GI) stromal tumours (GISTs) have had an effective response to systemic therapy. When treated with the signal transduction inhibitor STI 571, 59% of patients with this rare solid tumour had a partial response and 26% had disease stabilisation, representing an overall tumour control rate of 85%. These phase II data were reported at the 37th Annual Meeting of the American Society of Clinical Oncology (ASCO) [San Francisco, US; May 2001] along with data from a smaller phase I trial which also showed an improvement in most patients treated with the drug. STI 571 recently hit the headlines following extremely positive results in patients with chronic myeloid leukaemia (CML)*and was approved in the US just days before this year's ASCO meeting for the treatment of patients with CML in blast crisis, accelerated phase or chronic phase in whom treatment with interferon has failed.**
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
7. |
Ezetimibe lowers LDL-cholesterol levels |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
8. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
9. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
10. |
The ups and downs of symptom management in patients with cancer |
|
Inpharma Weekly,
Volume &NA;,
Issue 1291,
2001,
Page 11-12
Carmen Innes,
Preview
|
|
摘要:
'Attention to quality-of-life issues and the integration of symptom management is becoming an essential component of cancer care',says Dr Jamie Von Roenn from Northwestern University, Chicago, US. She adds that symptom management in patients with cancer should never be reserved for the end of life. Physicians need to look at common symptoms that are not necessarily related to cancer (such as depression) which when treated, obviously improve quality of life (QOL) whether a patient's disease is curable or not. Dr Von Roenn spoke at a press conference at the 37th Annual Meeting of the American Society of Clinical Oncology [San Francisco, US; May 2001], where several studies examining patients' QOL during cancer treatment were reported.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|